Skip to main content
Top
Published in: Head and Neck Pathology 2/2013

01-06-2013 | Case Report

A Case of Age-Related Epstein–Barr Virus (EBV)-Associated B Cell Lymphoproliferative Disorder, so-called Polymorphous Subtype, of the Mandible, with a Review of the Literature

Authors: Kentaro Kikuchi, Shuichi Fukunaga, Harumi Inoue, Yuji Miyazaki, Masaru Kojima, Fumio Ide, Kaoru Kusama

Published in: Head and Neck Pathology | Issue 2/2013

Login to get access

Abstract

Epstein–Barr virus (EBV) is known to be associated with the development of lymphomas in immunocompromised patients. Recently, age-related immune impairment has been recognized as a predisposing factor in the development of EBV-driven lymphoproliferative disorders (LPDs) in elderly patients without any known immunodeficiency or prior lymphoma. In approximately 70 % of reported cases, the affected sites have been extranodal, such as the skin, lung, tonsil and stomach. However, age-related EBV-associated B cell (EBV + B cell) LPD is extremely rare in the oral cavity. Here we report a 71-year-old Japanese man who developed an EBV + B cell LPD resembling classical Hodgkin lymphoma (CHL)—so-called polymorphous subtype—of the mandible. Histopathologically, infiltration of large atypical lymphoid cells including Hodgkin or Reed-Sternberg-like cells into granulation tissue with marked necrosis was found in the mandibular bone. Immunohistochemical analysis revealed that the large atypical Hodgkin or Reed-Sternberg-like cells were CD3–, CD15–, CD20+, CD30+ and Epstein–Barr virus (EBV)-latent infection membrane protein-1 (LMP-1)+. In situ hybridization (ISH) demonstrated EBV-encoded small RNA (EBER) + in numerous Hodgkin or Reed-Sternberg-like cells. EBNA-2 was detected by polymerase chain reaction (PCR) using an extract from the formalin-fixed, paraffin-embedded specimen. To our knowledge, this is the first reported case of the polymorphous subtype of age-related EBV + B cell LPD affecting the mandible.
Literature
1.
go back to reference Oyama T, Ichimura K, Suzuki R, et al. Senile EBV + B-cell lymphoproliferative disorders: a clinicopathological study of 22 patients. Am J Surg Pathol. 2003;27:16–26.PubMedCrossRef Oyama T, Ichimura K, Suzuki R, et al. Senile EBV + B-cell lymphoproliferative disorders: a clinicopathological study of 22 patients. Am J Surg Pathol. 2003;27:16–26.PubMedCrossRef
2.
go back to reference Borisch B, Raphael M, Swerdlow SH, Jaffe ES, et al. Immunodeficiency associated lymphoproliferative disorders. In: Harris NL, Stein H, Vardiman JW, Jaffe ES, editors. World Health Organization Classification of Tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001. p. 255–71. Borisch B, Raphael M, Swerdlow SH, Jaffe ES, et al. Immunodeficiency associated lymphoproliferative disorders. In: Harris NL, Stein H, Vardiman JW, Jaffe ES, editors. World Health Organization Classification of Tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001. p. 255–71.
3.
go back to reference Oyama T, Yamamoto K, Asano N, et al. Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinico pathologic group: a study of 96 patients. Clin Cancer Res. 2007;13:5124–32.PubMedCrossRef Oyama T, Yamamoto K, Asano N, et al. Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinico pathologic group: a study of 96 patients. Clin Cancer Res. 2007;13:5124–32.PubMedCrossRef
4.
go back to reference Nakamura S, Jaffe ES, Swerdlow SH. EBV-positive diffuse large B-cell lymphoma of the elderly. In: Swerdlow SJ, Campo E, Harris NL, Jaff ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008. p. 243–4. Nakamura S, Jaffe ES, Swerdlow SH. EBV-positive diffuse large B-cell lymphoma of the elderly. In: Swerdlow SJ, Campo E, Harris NL, Jaff ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008. p. 243–4.
5.
go back to reference Shimoyama Y, Asano N, Kojima M, et al. Age-related EBV-associated B-cell lymphoproliferative disorders: diagnostic approach to a newly recognized clinicopathological entity. Pathol Int. 2009;59:835–43.PubMedCrossRef Shimoyama Y, Asano N, Kojima M, et al. Age-related EBV-associated B-cell lymphoproliferative disorders: diagnostic approach to a newly recognized clinicopathological entity. Pathol Int. 2009;59:835–43.PubMedCrossRef
6.
go back to reference Asano N, Yamamoto K, Tamaru J, et al. Age-related Epstein–Barr virus (EBV)-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly. Blood. 2009;113:2629–36.PubMedCrossRef Asano N, Yamamoto K, Tamaru J, et al. Age-related Epstein–Barr virus (EBV)-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly. Blood. 2009;113:2629–36.PubMedCrossRef
7.
go back to reference Dojcinov SD, Venkataraman G, Raffeld M, et al. EBV-positive mucocutaneous ulcer: a study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol. 2010;34:405–17.PubMedCrossRef Dojcinov SD, Venkataraman G, Raffeld M, et al. EBV-positive mucocutaneous ulcer: a study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol. 2010;34:405–17.PubMedCrossRef
8.
go back to reference Dojcinov SD, Venkataraman G, Pittaluga S, et al. Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma. Blood. 2011;117:4726–35.PubMedCrossRef Dojcinov SD, Venkataraman G, Pittaluga S, et al. Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma. Blood. 2011;117:4726–35.PubMedCrossRef
9.
go back to reference Kamel OW, Weiss LM, van de Rijn M, et al. Hodgkin’s disease and lymphoproliferations resembling Hodgkin’s disease in patients receiving long-term low-dose methotrexate therapy. Am J Surg Pathol. 1996;20:1279–87.PubMedCrossRef Kamel OW, Weiss LM, van de Rijn M, et al. Hodgkin’s disease and lymphoproliferations resembling Hodgkin’s disease in patients receiving long-term low-dose methotrexate therapy. Am J Surg Pathol. 1996;20:1279–87.PubMedCrossRef
10.
go back to reference Shimoyama Y, Oyama T, Asano N, et al. Senile Epstein–Barr virus-associated B-cell lymphoproliferative disorders: a mini review. J Clin Exp Hematopathol. 2006;46:1–4.CrossRef Shimoyama Y, Oyama T, Asano N, et al. Senile Epstein–Barr virus-associated B-cell lymphoproliferative disorders: a mini review. J Clin Exp Hematopathol. 2006;46:1–4.CrossRef
11.
go back to reference Kikuchi K, Miyazaki Y, Tanaka A, et al. Methotrexate-related Epstein–Barr virus (EBV)-associated lymphoproliferative disorder—so-called “Hodgkin-like lesion”—of the oral cavity in a patient with rheumatoid arthritis. Head Neck Pathol. 2010;4:305–11.PubMedCrossRef Kikuchi K, Miyazaki Y, Tanaka A, et al. Methotrexate-related Epstein–Barr virus (EBV)-associated lymphoproliferative disorder—so-called “Hodgkin-like lesion”—of the oral cavity in a patient with rheumatoid arthritis. Head Neck Pathol. 2010;4:305–11.PubMedCrossRef
12.
go back to reference Ambinder RF. Epstein–Barr virus-associated lymphoproliferative disorders. Rev Clin Exp Hematol. 2003;7:362–74.PubMed Ambinder RF. Epstein–Barr virus-associated lymphoproliferative disorders. Rev Clin Exp Hematol. 2003;7:362–74.PubMed
13.
go back to reference Diebold J, Jaffe ES, Raphael M, Warnke RA. Burkitt lymphoma. In: Harris NL, Stein H, Vardiman JW, Jaffe ES, editors. World Health Organization Classification of Tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001. p. 181–5. Diebold J, Jaffe ES, Raphael M, Warnke RA. Burkitt lymphoma. In: Harris NL, Stein H, Vardiman JW, Jaffe ES, editors. World Health Organization Classification of Tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001. p. 181–5.
14.
go back to reference Chan JKC, Jaffe ES, Ralfkiaer E. Extranodal NK/T-cell lymphoma, nasal type. In: Harris NL, Stein H, Vardiman JW, Jaffe ES, editors. World Health Organization Classification of Tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001. p. 204–7. Chan JKC, Jaffe ES, Ralfkiaer E. Extranodal NK/T-cell lymphoma, nasal type. In: Harris NL, Stein H, Vardiman JW, Jaffe ES, editors. World Health Organization Classification of Tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001. p. 204–7.
15.
go back to reference Jaffe ES, Harris NL, Swerdlow SJ, et al. Immunodeficiency-associated lymphoproliferative disorder. In: Swerdlow SJ, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO classification of tumors of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008. p. 335–51. Jaffe ES, Harris NL, Swerdlow SJ, et al. Immunodeficiency-associated lymphoproliferative disorder. In: Swerdlow SJ, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO classification of tumors of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008. p. 335–51.
16.
go back to reference Shimoyama Y, Yamamoto K, Asano N, et al. Age-related Epstein–Barr virus-associated B-cell lymphoproliferative disorders: special references to lymphomas surrounding this newly recognized clinicopathologic disease. Cancer Sci. 2008;99:1085–91.PubMedCrossRef Shimoyama Y, Yamamoto K, Asano N, et al. Age-related Epstein–Barr virus-associated B-cell lymphoproliferative disorders: special references to lymphomas surrounding this newly recognized clinicopathologic disease. Cancer Sci. 2008;99:1085–91.PubMedCrossRef
17.
go back to reference Murase T, Fujita A, Ueno H, et al. A case of age-related EBV-associated B-cell lymphoproliferative disorder metachronously showing two distinct morphologic appearance, one of a polymorphic disease resembling classical Hodgkin lymphoma, and the othere of a large-cell lymphoma. Int Hematol. 2009;89:80–5.CrossRef Murase T, Fujita A, Ueno H, et al. A case of age-related EBV-associated B-cell lymphoproliferative disorder metachronously showing two distinct morphologic appearance, one of a polymorphic disease resembling classical Hodgkin lymphoma, and the othere of a large-cell lymphoma. Int Hematol. 2009;89:80–5.CrossRef
18.
go back to reference Park S, Lee J, Ko YH, et al. The impact of Epstein–Barr virus on clinical outcome in diffuse lage B-cell lymphoma. Blood. 2007;110:972–8.PubMedCrossRef Park S, Lee J, Ko YH, et al. The impact of Epstein–Barr virus on clinical outcome in diffuse lage B-cell lymphoma. Blood. 2007;110:972–8.PubMedCrossRef
19.
go back to reference Sarah E, Gibson MD, Eric D, et al. Epstein–Barr virus-positive B-cell lymphoma of the elderly at a United States tertiary medical center: an uncommon aggressive lymphoma with a nongerminal center B-cell phenotype. Hum Pathol. 2009;40:653–61.CrossRef Sarah E, Gibson MD, Eric D, et al. Epstein–Barr virus-positive B-cell lymphoma of the elderly at a United States tertiary medical center: an uncommon aggressive lymphoma with a nongerminal center B-cell phenotype. Hum Pathol. 2009;40:653–61.CrossRef
20.
go back to reference Tanaka A, Shigematsu H, Kojima M, et al. Methotrexate-associated lymphoproliferative disorder arising in a patient with adult Still’s disease. J Oral Maxillofac Surg. 2008;66:1492–5.PubMedCrossRef Tanaka A, Shigematsu H, Kojima M, et al. Methotrexate-associated lymphoproliferative disorder arising in a patient with adult Still’s disease. J Oral Maxillofac Surg. 2008;66:1492–5.PubMedCrossRef
21.
go back to reference Hernádi K, Szalmás A, Mogyorósi R, et al. Prevalence and activity of Epstein–Barr virus and human cytomegalovirus in symptomatic and asymptomatic apical periodontitis lesions. JOE. 2010;36:1485–9.PubMed Hernádi K, Szalmás A, Mogyorósi R, et al. Prevalence and activity of Epstein–Barr virus and human cytomegalovirus in symptomatic and asymptomatic apical periodontitis lesions. JOE. 2010;36:1485–9.PubMed
22.
go back to reference Sabeti M, Kermani V, Sabeti S, et al. Significance of human cytomegalovirus and Epstein–Barr virus in inducing cytokine expression in periapical lesions. JOE. 2012;38:47–50.PubMed Sabeti M, Kermani V, Sabeti S, et al. Significance of human cytomegalovirus and Epstein–Barr virus in inducing cytokine expression in periapical lesions. JOE. 2012;38:47–50.PubMed
23.
go back to reference Li H, Chen V, Chen Y, et al. Herpesviruses in endodontic pathoses: association of Epstein–Barr virus with irreversible pulpitis and apical periodontitis. JOE. 2009;35:23–9.PubMed Li H, Chen V, Chen Y, et al. Herpesviruses in endodontic pathoses: association of Epstein–Barr virus with irreversible pulpitis and apical periodontitis. JOE. 2009;35:23–9.PubMed
24.
go back to reference Contreras A, Nowzari H, Slots J. Herpesviruses in periodontal pocket and gingival tissue specimens. Oral Microbiol Immunol. 2000;15:15–8.PubMedCrossRef Contreras A, Nowzari H, Slots J. Herpesviruses in periodontal pocket and gingival tissue specimens. Oral Microbiol Immunol. 2000;15:15–8.PubMedCrossRef
25.
go back to reference Bilichodmath S, Mangalekar SB, Sharma DCG, et al. Herpesviruses in chronic and aggressive periodontitis patients in an Indian population. J Oral Sci. 2009;51:79–86.PubMedCrossRef Bilichodmath S, Mangalekar SB, Sharma DCG, et al. Herpesviruses in chronic and aggressive periodontitis patients in an Indian population. J Oral Sci. 2009;51:79–86.PubMedCrossRef
26.
go back to reference Nibali L, Atkinson C, Griffiths P, et al. Low prevalence of subgingival viruses in periodontitis patients. J Clin Periodontol. 2009;36:928–32.PubMedCrossRef Nibali L, Atkinson C, Griffiths P, et al. Low prevalence of subgingival viruses in periodontitis patients. J Clin Periodontol. 2009;36:928–32.PubMedCrossRef
27.
go back to reference Slot J, Saygun I, Sabeti M, et al. Epstein–Barr virus in oral diseases. J Periodont Res. 2006;41:235–44.CrossRef Slot J, Saygun I, Sabeti M, et al. Epstein–Barr virus in oral diseases. J Periodont Res. 2006;41:235–44.CrossRef
28.
go back to reference Casarin RC, Duarte PM, Santos VR, et al. Influence of glycemic control on Epstein–Barr and cytomegalovirus infection in periodontal pocket of type 2 diabetic subjects. Arch Oral Biol. 2010;55:902–6.PubMedCrossRef Casarin RC, Duarte PM, Santos VR, et al. Influence of glycemic control on Epstein–Barr and cytomegalovirus infection in periodontal pocket of type 2 diabetic subjects. Arch Oral Biol. 2010;55:902–6.PubMedCrossRef
29.
go back to reference Kimura H, Ito Y, Suzuki R, et al. Measuring Epstein–Barr virus (EBV) load: the significance and application for each EBV-associated disease. Rev Med Virol. 2008;18:305–19.PubMedCrossRef Kimura H, Ito Y, Suzuki R, et al. Measuring Epstein–Barr virus (EBV) load: the significance and application for each EBV-associated disease. Rev Med Virol. 2008;18:305–19.PubMedCrossRef
30.
31.
go back to reference Dawson DR III, Wang C, Danaher RJ, et al. Real-time polymerase chain reaction to determine the prevalence and copy number of Epstein–Barr virus and cytomegalovirus DNA in subgingival plaque at individual healthy and periodontal disease sites. J Periodontol. 2009;80:1133–40.PubMedCrossRef Dawson DR III, Wang C, Danaher RJ, et al. Real-time polymerase chain reaction to determine the prevalence and copy number of Epstein–Barr virus and cytomegalovirus DNA in subgingival plaque at individual healthy and periodontal disease sites. J Periodontol. 2009;80:1133–40.PubMedCrossRef
32.
go back to reference Imai K, Ochiai K, Okamoto T. Reactivation of latent HIV-1 infection by the periodontopathic bacterium Porphyromonas gingivalis involves histone modification. J Immunol. 2009;182:3688–95.PubMedCrossRef Imai K, Ochiai K, Okamoto T. Reactivation of latent HIV-1 infection by the periodontopathic bacterium Porphyromonas gingivalis involves histone modification. J Immunol. 2009;182:3688–95.PubMedCrossRef
33.
go back to reference Imai K, Inoue H, Tamura M, Cueno ME, Inoue H, Takeichi O, Kusama K, Saito I, Ochiai K. The periodontal pathogen Porphyromonas gingivalis induces the Epstein–Barr virus lytic switch transactivator ZEBRA by histone modification. Biochimie. 2012;94:839–46.PubMedCrossRef Imai K, Inoue H, Tamura M, Cueno ME, Inoue H, Takeichi O, Kusama K, Saito I, Ochiai K. The periodontal pathogen Porphyromonas gingivalis induces the Epstein–Barr virus lytic switch transactivator ZEBRA by histone modification. Biochimie. 2012;94:839–46.PubMedCrossRef
Metadata
Title
A Case of Age-Related Epstein–Barr Virus (EBV)-Associated B Cell Lymphoproliferative Disorder, so-called Polymorphous Subtype, of the Mandible, with a Review of the Literature
Authors
Kentaro Kikuchi
Shuichi Fukunaga
Harumi Inoue
Yuji Miyazaki
Masaru Kojima
Fumio Ide
Kaoru Kusama
Publication date
01-06-2013
Publisher
Springer US
Published in
Head and Neck Pathology / Issue 2/2013
Electronic ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-012-0392-1

Other articles of this Issue 2/2013

Head and Neck Pathology 2/2013 Go to the issue